Tag: DuoBody
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase...
Investigational Acasunlimab Shows Promising Results in Phase 2 Trial for Metastatic Lung CancerMedia Release COPENHAGEN, Denmark, and MAINZ, Germany; June 1, 2024
Initial data from...